Clinical Trial Update: Effect of a Ghrelin Receptor Agonist on Muscle and Bone [Phase 1]

View source ↗

Summary

Phase 1 clinical trial evaluating a ghrelin receptor agonist for effects on muscle and bone in sarcopenia and osteopenia; study completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteopenia
• Sarcopenia

Snippet

Sponsor: Tufts University | Conditions: Sarcopenia, Osteopenia | Phase 1 | Status: COMPLETED | Results posted: 2024-03-27